3
Announcements
Trials
Browse
Landscape
Phase
Phase 1
1
Status
Withdrawn
1
Sponsor Class
OTHER
1
Study Type
Interventional
1
Sponsor
Cancer Type
CNS
1
Conditions
Breast Neoplasms
13
Neoplasms
12
Colorectal Neoplasms
12
Pain
11
Pain, Postoperative
9
Prostatic Neoplasms
7
Lung Neoplasms
7
Agnosia
6
Colonic Neoplasms
5
Cancer Pain
5
Neuralgia
4
Keratosis, Actinic
4
Head and Neck Neoplasms
4
Liver Neoplasms
3
Leiomyoma
3
Chronic Pain
3
Thyroid Neoplasms
2
Stomatitis
2
Stomach Neoplasms
2
Recurrence
2
Pilonidal Sinus
2
Oropharyngeal Neoplasms
2
Neuroma
2
Neoplasm Metastasis
2
Myofibroma
2
Mucositis
2
Inflammatory Bowel Diseases
2
Ileus
2
Diverticulitis
2
Carcinoma, Non-Small-Cell Lung
2
Interventions
Temozolomide
162
Radiosurgery
115
Radiotherapy
100
Bevacizumab
96
Magnetic Resonance Spectroscopy
65
Carboplatin
48
Etoposide
34
pembrolizumab
33
Surgical Procedures, Operative
33
Irinotecan
33
Nivolumab
32
Cyclophosphamide
32
Erlotinib Hydrochloride
31
Radiation
30
Carmustine
28
Lomustine
25
Cisplatin
25
Trastuzumab
23
Ipilimumab
23
Filgrastim
23
Vincristine
20
Mental Status and Dementia Tests
20
Aminolevulinic Acid
19
Topotecan
18
Pemetrexed
18
Capecitabine
18
Specimen Handling
17
Sorafenib
15
Radiotherapy, Intensity-Modulated
15
Imatinib Mesylate
15
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
1 trials
Recent
Start date
Enrollment
Interventional
×
Brain Neoplasms
×
Lidocaine
×
Clear all
NCT03177252
2020-10-22
Scalp block
Washington University School of Medicine
Phase 1
Withdrawn